| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA3224132 | F | Ratio of oseltamivir carboxylate EC50 to compound EC50 for Influenza B virus (B/Harbin/07/94) infected in MDCK cells assessed as reduction of virus-induced cytopathic effect after 72 hrs by MTT assay | Influenza B virus | 4 | cell-based format | Scientific Literature | ||
| 2. | ALA3224133 | F | Ratio of zanamivir EC50 to compound EC50 for Influenza B virus (B/Harbin/07/94) infected in MDCK cells assessed as reduction of virus-induced cytopathic effect after 72 hrs by MTT assay | Influenza B virus | 4 | cell-based format | Scientific Literature | ||
| 3. | ALA3224134 | F | Ratio of zanamivir EC50 to compound EC50 for Influenza A virus (A/Sydney/5/1997(H3N2)) infected in MDCK cells assessed as reduction of virus-induced cytopathic effect after 72 hrs by MTT assay | Influenza A virus (A/Sydney/5/1997(H3N2)) | 4 | cell-based format | Scientific Literature | ||
| 4. | ALA3224135 | F | Ratio of oseltamivir carboxylate EC50 to compound EC50 for Influenza A virus (A/Sydney/5/1997(H3N2)) infected in MDCK cells assessed as reduction of virus-induced cytopathic effect after 72 hrs by MTT assay | Influenza A virus (A/Sydney/5/1997(H3N2)) | 4 | cell-based format | Scientific Literature | ||
| 5. | ALA3224136 | F | Antiviral activity against Influenza B virus (B/Harbin/07/94) infected in MDCK cells assessed as reduction of virus-induced cytopathic effect after 72 hrs by MTT assay | Influenza B virus | 9 | cell-based format | Scientific Literature | ||
| 6. | ALA3224508 | F | Antiviral activity against Influenza A virus (A/Sydney/5/1997(H3N2)) infected in MDCK cells assessed as reduction of virus-induced cytopathic effect after 72 hrs by MTT assay | Influenza A virus (A/Sydney/5/1997(H3N2)) | 9 | cell-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!